Product information
From Health Canada
Current status:
Dormant
Current status date:
2017-06-22
Original market date: See footnote 1
1997-05-28
Product name:
RELEFACT TRH INJECTION 200MCG/ML
DIN:
02224615 Electronic product monograph is not available
Company:
ODAN LABORATORIES LTD
325 Stillview Avenue
Pointe-Claire
Quebec
Canada
H9R 2Y6
Class:
Human
Dosage form(s):
Liquid
Route(s) of administration:
Intravenous
Number of active ingredient(s):
1
Schedule(s):
Prescription
American Hospital Formulary Service (AHFS): See footnote 3
36:60.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
V04CJ02 PROTIRELIN
Active ingredient group (AIG) number:See footnote5
0111428001
Active ingredient(s) | Strength |
---|---|
PROTIRELIN | 200 MCG / ML |